Redefining the relationship between the pharmaceutical industry and patients

Redefining the relationship between the pharmaceutical industry and patients

Hu-manity.co, which claims to be ‘the world’s first and only organisation developing human rights and corollary sovereign laws in a decentralised manner on blockchains’, will join the global pharmaceutical conversation around the impact of blockchain on the relationship between the pharmaceutical industry, patients and patient data.

The company will take part in a four-person discussion involving Sanofi Pharmaceuticals, Hugo Health and Yale University School of Medicine that will focus on using blockchain as a catalyst to redefine the relationship between the pharmaceutical industry and patients.

“We are at an ethical inflection point in the use of digital and bio-technologies, AI and big data,” said Jennifer E. Miller, Assistant Professor at Yale University School of Medicine and a founder of Bioethics International. “People should know the data being collected, used and sold about them, especially data related to their health. Data privacy, transparency and ownership issues need to be addressed.”